Determinants and burden of chronic kidney disease in the population-based CoLaus study: A cross-sectional analysis

Nephrology Dialysis Transplantation

Volumn 28, Issue 9, 2013, Pages 2329-2339

  Ponte, Belén ^a   Pruijm, Menno ^b   Marques Vidal, Pedro ^c   Martin, Pierre Yves ^a   Burnier, Michel ^b   Paccaud, Fred ^c   Waeber, Gérard ^b   Vollenweider, Peter ^b   Bochud, Murielle ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Chronic kidney disease; CKD EPI equation; MDRD equation; Population based study; Prevalence

Indexed keywords

CREATININE; HOMOCYSTEINE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALBUMIN TO CREATININE RATIO; ANALYTIC METHOD; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MODIFICATION OF DIET IN RENAL DISEASE EQUATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CODING; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SWITZERLAND; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

CHRONIC KIDNEY DISEASE; CKD-EPI EQUATION; MDRD EQUATION; POPULATION-BASED STUDY; PREVALENCE;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SWITZERLAND;

EID: 84884514931     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft206     Document Type: Article

References (61)

1. Gilbertson DT, Liu J, Xue JL et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005; 16: 3736-3741
2. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663
3. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with allcause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
4. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50: 169-180
5. Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. Br Med J 2006; 333: 1047
6. Hoerger TJ, Wittenborn JS, Segel JE et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis 2010; 55: 463-473
7. Stevens LA, Coresh J, Greene T et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483
8. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
9. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
10. Stevens LA, Coresh J, Feldman HI et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18: 2749-2757
11. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
12. Stevens LA, Schmid CH, Greene T et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 2010; 56: 486-495
13. Matsushita K, Mahmoodi BK, Woodward M et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941-1951
14. van der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011; 79: 1341-1352
15. Tonelli M, Muntner P, Lloyd A et al. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med 2011; 154: 12-21
16. Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28
17. van den Brand JA, van Boekel GA, Willems HL et al. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant 2011; 26: 3176-3181
18. White SL, Polkinghorne KR, Atkins RC et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the Aus Diab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010; 55: 660-670
19. Matsushita K, Selvin E, Bash LD et al. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010; 55: 648-659
20. Shafi T, Matsushita K, Selvin E et al. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol 2012; 13: 42
21. Matsushita K, Tonelli M, Lloyd A et al. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR. Am J Kidney Dis 2012; 60: 241-249
22. O'Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open 2011; 1: e000308
23. Firmann M, Mayor V, Vidal PM et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008; 8: 6
24. El Assaad MA, Topouchian JA, Darne BM et al. Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit 2002; 7: 237-241
25. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes care 2010; 33(Suppl 1): S11-S61
26. Stevens LA, Greene T, Levey AS. Surrogate end points for clinical trials of kidney disease progression. Clin J Am Soc Nephrol 2006; 1: 874-884
27. Brosius FC, 3rd, Hostetter TH, Kelepouris E et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 2006; 114: 1083-1087
28. Gansevoort RT, Matsushita K, van der Velde M et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80: 93-104
29. Astor BC, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative metaanalysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
30. Kessler R, Keusch G, Szucs T et al. Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland. Swiss Med Wkly 2012; 142: 0
31. Nitsch D, Felber Dietrich D, von Eckardstein A et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 2006; 21: 935-944
32. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117
33. McCullough K, Sharma P, Ali T et al. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant 2012; 27: 1812-1821
34. Viktorsdottir O, Palsson R, Andresdottir MB et al. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 2005; 20: 1799-1807
35. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
36. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284
37. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373-384
38. Chen W, Wang H, Dong X et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 2009; 24: 1205-1212
39. Gambaro G, Yabarek T, Graziani MS et al. Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol 2010; 5: 1946-1953
40. Otero A, Gayoso P, Garcia F et al. Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study. Kidney Int Suppl 2005; 99: S16-S19
41. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: the Aus Diab kidney study. J Am Soc Nephrol 2003; 14: S131-S138
42. Whaley-Connell AT, Sowers JR, Stevens LA et al. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S13-S20
43. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5(Suppl A): S3-S10
44. Halbesma N, Brantsma AH, Bakker SJ et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int 2008; 74: 505-512
45. Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010; 33: 383-392
46. Lyngdoh T, Vuistiner P, Marques-Vidal P et al. Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach. PLoS One 2012; 7: e39321
47. Munkhaugen J, Lydersen S, Wideroe TE et al. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis 2009; 54: 638-646
48. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850
49. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
50. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008; 73: 19-33
51. Ninomiya T, Kiyohara Y, Kubo M et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis 2004; 44: 437-445
52. Jager A, Kostense PJ, Nijpels G et al. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol 2001; 21: 74-81
53. Marti F, Vollenweider P, Marques-Vidal PM et al. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health 2011; 11: 733
54. Chen N, Wang W, Huang Y et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 2009; 24: 2117-2123
55. Chang HY, Tung CW, Lee PH et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population. Am J Med Sci 2010; 339: 509-515
56. Obermayr RP, Temml C, Gutjahr G et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008; 19: 2407-2413
57. Bellomo G, Venanzi S, Verdura C et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 2010; 56: 264-272
58. Sonoda H, Takase H, Dohi Y et al. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol 2011; 33: 352-357
59. Upchurch GR, Jr, Welch GN, Fabian AJ et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272: 17012-17017
60. Kang DH, Park SK, Lee IK et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562
61. Vickery S, Stevens PE, Dalton RN et al. Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 2006; 21:2439-2445